沃特世公司
WAT
436.95
-7.20
-1.62%
沃特世公司
US · WAT
#515 按市值排名
上市于 1970
436.95
-7.20
-1.62%
实时 - 追踪5344个代码 - 心跳于21秒前
· 2026-10-16 16:59
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了8家。
- 机构持股总比例下降了1.1个百分点。
机构持股
- 机构持股比例
- 101.47% -1.15pp
- 机构数量
- 1,403 -8
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund86.06%
Hedge Fund8.41%
Public Company3.00%
Government Pension Fund1.49%
Private Company1.26%
VC/PE Fund0.29%
Insurance Company0.26%
Sovereign Wealth Fund0.25%
Family Office/Trust0.18%
主要股东 截至 2026-06-30
BlackRock
8.64% · 8.48M 股
Vanguard Capital Management, LLC
7.09% · 6.97M 股
T. Rowe Price Group, Inc.
6.10% · 6.00M 股
Vanguard Portfolio Management, LLC
4.83% · 4.74M 股
MFS Investment Management
4.71% · 4.63M 股
State Street Global Advisors
4.46% · 4.38M 股
AllianceBernstein
2.74% · 2.69M 股
Geode Capital Management, LLC
2.68% · 2.64M 股
Invesco Ltd.
2.53% · 2.48M 股
Fundsmith, LLP
2.31% · 2.27M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 38次买入 · 11次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Udit Batra | Chief Executive Officer | 0.03% |
| Christopher Kuebler | Independent Director | 0.02% |
| Amol Chaubal | Senior Vice President | 0.01% |
| Flemming Ornskov | Independent Chairperson | 0.01% |
| Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | 0.01% |
| Mark Vergnano | Independent Director | 0.00% |
| Wei Jiang | Independent Director | 0.00% |
| Richard Fearon | Independent Director | 0.00% |
| Linda Baddour | Independent Director | 0.00% |
| Pearl Huang | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-29 | Wei Jiang | Independent Director | Other Acquisition | +57 | -- |
| 2026-09-29 | Heather Knight | Director | Other Acquisition | +57 | -- |
| 2026-08-05 | Christopher Kuebler | Independent Director | Derivative Exercise and Sale | -3,626 | $136.43–397.94 |
| 2026-06-29 | Wei Jiang | Independent Director | Other Acquisition | +67 | -- |
| 2026-06-29 | Heather Knight | Director | Other Acquisition | +63 | -- |
| 2026-06-23 | Robert Carpio | Senior Vice President of Waters Division | Sale to Issuer | -189 | $369.18 |
| 2026-05-11 | Amol Chaubal | Senior Vice President | Sale to Issuer | -239 | $352.21 |
| 2026-04-05 | Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | Sale to Issuer | -302 | $304.09 |
| 2026-03-30 | Wei Jiang | Independent Director | Other Acquisition | +64 | -- |
| 2026-03-30 | Heather Knight | Director | Other Acquisition | +68 | -- |
| 2026-03-15 | Wei Jiang | Independent Director | Open Market Acquisition | +500 | $289.46 |
| 2026-03-05 | Richard Fearon | Independent Director | Open Market Acquisition | +1,000 | $306.34 |
| 2026-03-01 | Udit Batra | Chief Executive Officer | Sale to Issuer | -3,417 | $307.23 |
| 2026-03-01 | Jianqing Bennett | Senior Vice President of TA Instruments Division & Waters Clinical Business Unit | Sale to Issuer | -410 | $307.23 |
| 2026-03-01 | Amol Chaubal | Senior Vice President | Sale to Issuer | -709 | $307.23 |
| 2026-02-24 | Linda Baddour | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Linda Baddour | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Acquisition | +23 | -- |
| 2026-02-24 | Christopher Kuebler | Independent Director | Other Derivative Acquisition | +57 | $319.44 |
| 2026-02-24 | Richard Fearon | Independent Director | Other Acquisition | +23 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 16:59:11 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
沃特世公司 讨论区 0 条评论